F-18 FDG uptake in the nidus of an osteoid osteoma

Clinical Nuclear Medicine

Volumn 32, Issue 8, 2007, Pages 628-630

  Lim, Chae Hun ^a   Park, Young Ha ^a   Lee, Sung Yong ^b   Chung, Soo Kyo ^c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Fluorodeoxyglucose; Nidus; Osteoid osteoma; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADULT; ANKLE PAIN; ARTICLE; BENIGN TUMOR; CASE REPORT; DISEASE DURATION; FEMALE; HUMAN; METAPHYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOID OSTEOMA; POSITRON EMISSION TOMOGRAPHY; TIBIA;

ADULT; BONE NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; OSTEOMA, OSTEOID; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIBIA;

EID: 34547674790     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3180a1acf3     Document Type: Article

References (9)

1. Dahlin DC, Unni KK. Bone Tumors: General Aspects and Data on 8,542 Cases. 4th ed. Springfield, IL: Thomas; 1987:88-101.
2. Resnick D, Kransdorf M. Bone and Joint Imaging. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2004.
3. Helms CA, Hattner RS, Vogler JB. Osteoid osteoma: radionuclide diagnosis. Radiology. 1984;151:779-784.
4. Goodin GS, Shulkin BL, Kaufman RA, et al. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol. 2006;187:1124-1128.
5. Aoki J, Endo K, Watanabe H, et al. FDG-PET for evaluating musculoskeletal tumors. J Orthop Sci. 2003;8:435-441.
6. Aoki J, Inoue T, Tomiyoshi K, et al. Nuclear imaging of bone tumors: FDG-PET. Semin Musculoskelet Radiol. 2001;5:183-187.
7. Feldman F, van Heertum R, Manos C. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol. 2003;32:201-208.
8. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774-777.
9. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, et al. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med. 2002;43:510-518.